Obesity
Showing NaN - NaN of 27
Overweight, Obesity and Diabetes, Type 2 Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)
Not yet recruiting
- Overweight
- +2 more
- Cagrilintide
- +3 more
-
Concord, California
- +147 more
Jan 24, 2023
Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Overweight
- Obesity
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +804 more
Dec 19, 2022
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Santa Monica, California
- +31 more
Nov 18, 2022
Atrial Fibrillation, Obesity Trial in Calgary (CR with added BWLT)
Recruiting
- Atrial Fibrillation
- Obesity
- CR with added BWLT
-
Calgary, Alberta, CanadaUniversity of Calgary
Oct 31, 2022
Psoriatic Arthritis, Obesity Trial in Calgary (BWLT, Waitlist Control for BWLT)
Recruiting
- Psoriatic Arthritis
- Obesity
- BWLT
- Waitlist Control for BWLT
-
Calgary, Alberta, CanadaBehavioural Medicine Laboratory
May 16, 2022
Obesity, Albuminuria Trial in Worldwide (Semaglutide, Placebo)
Enrolling by invitation
- Obesity
- Albuminuria
- Semaglutide
- Placebo
-
Calgary, Alberta, Canada
- +12 more
Mar 25, 2022
Obesity Trial in Worldwide (Semaglutide 2.4 mg, Placebo)
Active, not recruiting
- Obesity
- Semaglutide 2.4 mg
- Placebo
-
Calgary, Alberta, Canada
- +21 more
Mar 22, 2022
Overweight, Obesity Trial in Canada, United States (Hockey FIT Program (Immediate Delivery))
Active, not recruiting
- Overweight
- Obesity
- Hockey FIT Program (Immediate Delivery)
-
Flint, Michigan
- +39 more
Nov 26, 2021
Obesity, Overweight Trial in Worldwide (Semaglutide 1.0 mg, Semaglutide 2.4 mg, Placebo I (Semaglutide))
Completed
- Obesity
- Overweight
- Semaglutide 1.0 mg
- +3 more
-
Buena Park, California
- +146 more
Nov 8, 2021
Osteo Arthritis Knee, Obesity Trial in Calgary (Prebiotic oligofructose-enriched inulin, Placebo maltodextrin)
Recruiting
- Osteo Arthritis Knee
- Obesity
- Prebiotic oligofructose-enriched inulin
- Placebo maltodextrin
-
Calgary, Alberta, CanadaUniversity of Calgary
Jul 12, 2021
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (semaglutide, liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- semaglutide
- +2 more
-
Anaheim, California
- +73 more
Apr 14, 2020
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (Liraglutide 3.0 mg, Placebo)
Completed
- Metabolism and Nutrition Disorder
- Obesity
- Liraglutide 3.0 mg
- Placebo
-
Birmingham, Alabama
- +53 more
Mar 13, 2020
Obesity Trial in Calgary (Pulse fibre, Control)
Completed
- Obesity
- Pulse fibre
- Control
-
Calgary, Alberta, CanadaUniversity of Calgary
Jan 16, 2020
Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)
Completed
- Cardiovascular Disease
- +4 more
- Lorcaserin hydrochloride
- Placebo
-
Alexander City, Alabama
- +498 more
Jun 27, 2019
Does Treating Obstructive Sleep Apnea in Obese Canadian Youth
Completed
- Obesity
- Obstructive Sleep Apnea
-
Calgary, Alberta, Canada
- +3 more
Mar 7, 2018
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Birmingham, Alabama
- +225 more
Dec 20, 2017
Obesity Trial in Calgary (Protein, Prebiotic fiber, Protein plus prebiotic fiber)
Completed
- Obesity
- Protein
- +3 more
-
Calgary, Alberta, CanadaUniversity of Calgary
Oct 24, 2017
Overweight, Obesity Trial in Calgary (Prebiotic fiber, Placebo)
Completed
- Overweight
- Obesity
- Prebiotic fiber
- Placebo
-
Calgary, Alberta, CanadaUniversity of Calgary
Oct 24, 2017
Obesity Trial in Calgary (Nutrition counseling + portion control tool, Nutrition counseling)
Completed
- Obesity
- Nutrition counseling + portion control tool
- Nutrition counseling
-
Calgary, Alberta, CanadaAlberta Children's Hospital
Aug 29, 2014
Lumbar Spinal Stenosis, Obesity Trial in Calgary (Lifestyle intervention)
Unknown status
- Lumbar Spinal Stenosis
- Obesity
- Lifestyle intervention
-
Calgary, Alberta, CanadaMount Royal University
Sep 9, 2013
Obesity Trial in Canada, United States (CP-945,598 Treatment A, CP-945,598 Treatment B, Placebo)
Terminated
- Obesity
- CP-945,598 Treatment A
- +2 more
-
Fairhope, Alabama
- +81 more
Nov 5, 2012